Identification of New Prognostic Markers for Breast Cancer.
NCT03436069
Summary
Candidate markers have been identified thanks to an original approach developed by our research team aiming at detecting ectopic gene expression using public pan-genomic breast cancer data. The same approach had already been used and validated in lung tumors, leukemias and lymphomas. The main objective of the present research is to use tumor samples from patients in a retrospective and prospective cohort to test and validate the relevance of these prognostic markers in breast cancer.
Eligibility
Inclusion Criteria: * Adult female patients with breast cancer Exclusion Criteria: * Presence of another cancer, excluding basal cell cancers or pre-neoplastic lesions of the cervix. * Subject under guardianship or subject deprived of liberty * Impossibility of collecting information on exposure (subjects recently arrived in France, foreign language, etc.) * Male patients
Conditions2
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT03436069